Abstract: The non-invasive method of assessing the reducing potential of culture medium of in vitro cultured embryos as part of an ART procedure serves as an alternative or supportive method to assess the viability of in vitro cultured embryos without doing any harm to the embryos.

Abstract: The non-invasive method of assessing the reducing potential of culture medium of in vitro cultured embryos as part of an ART procedure serves as an alternative or supportive method to assess the viability of in vitro cultured embryos without doing any ham to the embryos.

Abstract: The present invention teaches a bedside table with a disposable hygienic tray which has thereon multiple layers of film. Each layer of film in turn has adhesive, or anti-bacterial compounds, or bacterial detection compounds, or combinations thereof. In use, for example in a hospital, health care setting, home care setting or for home or many other contexts of use, each layer is removed in sequence, exposing a new layer underneath. After a suitable period of usage, the new layer is in turn removed to expose yet another later. When the final layer is removed the disposable tray is removed from the bedside table and replaced with a fresh tray. In embodiments, the core bedside table unit may sit on the floor, mount to a wall rail, or may have a projection dimensioned and configured to pass between the bottom of a mattress and the top of a box spring.

Abstract: The invention provides an in vitro method for non-invasive preimplantation assessment of an embryo by comprising amplifying and detecting a nucleic acid sequence of interest indicative of a genetic deficiency from a sample taken from the in vitro culture medium of the embryo and assessing the embryo as having a genetic deficiency if the presence of the sequence of interest is detected in the in vitro culture medium of the embryo. The examples show the detection of SNPs relating to the genes MDR1 and prothrombin and the SNP responsible for the Leiden syndrome. The application also mentions the possibility of establishing short tandem repeat (STR) marker profiles of DNA in the culture medium and full genome sequencing of the DNA in the culture medium as a means for determining embryo quality.

Abstract: A spliced fiber tow (40) having a uniform density along its entire length is provided. The spliced fiber tow is manufactured by rarefying the ends (22, 32) of the two fiber tow segments to be joined, aligning the rarefied regions (26, 36) and then applying pressurized gas to entangle the filaments in the rarefied regions. An apparatus (50) for forming the spliced fiber tow includes a pair of rarefying blades (86, 92) and an entanglement element (58).

Abstract: The invention relates to a device (10) and method for processing images (1) of the pulmonary circulation (2) of a living being in order to characterize the arterial blood flow, wherein a plurality of temporally successive images (1) are processed, said device having a selection interface (12) containing at least two defined locations (a, b, c) of an image (1), a unit (13) for assigning the at least two defined locations (a, b, c) to all images (1), a unit (14) for determining the density (D) at at least two defined locations (a, b, c) in all images (1), a unit (14) for calculating the density (D) for the defined locations (a, b, c) as a function (Fa, fa, fb, fc) of time (t), a unit (16) for analysing the at least one time difference (?b, ?c) between the maximum values (Ma, Mb, Mc) of the density (D) for the at least two defined locations (a, b, c) as a function of time (t), and a display (17) for the at least one time difference (?b, ?c).

Abstract: The present invention relates to a receiver in a 2×2 Line of Sight Multiple Input Multiple Output, LoS MIMO, system. The receiver is arranged to estimate a first (?1) and a second (?2) signal on the basis of a first (r1(t)) and a second (r2(t)) signal received from respective first and second transmitters (Tx1,Tx2). Said received signals (r1(t), r2(t) comprises a first and second signal. The receiver comprises a first Phase Locked Loop (11), PLL, and a second PLL (12), which are arranged to respectively determine a first (In1) and second (In2) demodulated signal from the first (r1(t)) and the second (r2(t)) received signals. The receiver further comprises an equalizer (13) which is arranged to estimate the first (?1) and second (?2) signals from the demodulated signals (In1,In2).

Abstract: A linear guide with a guide carriage longitudinally movably arranged on a guide rail, which is preferably U-shaped and a braking device effectively arranged between the guide rail and the guide carriage. An actuator for actuating the braking device is provided and the actuator has an electro-active polymer effectively arranged in the longitudinal axis of the linear guide which engages around the guide rail for actuating the braking device.

Abstract: The present invention relates to a receiver in a 2×2 Line of Sight Multiple Input Multiple Output, LoS MIMO, system. The receiver is arranged to estimate a first (?1) and a second (?2) signal on the basis of a first (r1(t)) and a second (r2(t)) signal received from respective first and second transmitters (Tx1,Tx2). Said received signals (r1(t), r2(t) comprises a first and second signal. The receiver comprises a first Phase Locked Loop (11), PLL, and a second PLL (12), which are arranged to respectively determine a first (In1) and second (In2) demodulated signal from the first (r1(t)) and the second (r2(t)) received signals. The receiver further comprises an equalizer (13) which is arranged to estimate the first (S1) and second (S2) signals from the demodulated signals (In1,In2).

Abstract: A spliced fiber tow (40) having a uniform density along its entire length is provided. The spliced fiber tow is manufactured by rarefying the ends (22, 32) of the two fiber tow segments to be joined, aligning the rarefied regions (26, 36) and then applying pressurized gas to entangle the filaments in the rarefied regions. An apparatus (50) for forming the spliced fiber tow includes a pair of rarefying blades (86, 92) and an entanglement element (58).

Abstract: In a method and apparatus for examination and evaluation of a blood flow in a pulmonary artery of a patient, measurement data are recorded, from which at least a part of the blood flow in the pulmonary artery is able to be re-constructed at least two-dimensionally in a plane defined by a longitudinal axis of the pulmonary artery and by an anterior-posterior direction, including at least at several diastolic points in time in the course of a heart cycle, after a closure of the pulmonary valve. The number of diastolic points for which an asymmetry in relation to the longitudinal axis of the pulmonary artery in the anterior-posterior direction exists is determined. A measure is then determined that characterizes how long, after the closure of the pulmonary valve, the aforementioned asymmetry exists.

Abstract: A linear guide with a guide carriage longitudinally movably arranged on a guide rail, which is preferably U-shaped and a braking device effectively arranged between the guide rail and the guide carriage. An actuator for actuating the braking device is provided and the actuator has an electro-active polymer effectively arranged in the longitudinal axis of the linear guide which engages around the guide rail for actuating the braking device.

Abstract: A lighter-than-air aircraft is propelled via a bending-rotating tail whip. Two actuating areas located on opposite sides in a rear area of a lifting gas body are shortened by activated actuators. A vertical plane of symmetry of the lifting gas body and thus, the lifting gas body itself, are pivoted in an area of bending zones about angles a and ?. An activated state exists when the actuator performs work for propelling the aircraft. Propulsion can be provided by deformation of the lifting gas body. Changes in direction can also be effected by asymmetrical sequences of movements.

Abstract: In a method and apparatus for examination and evaluation of a human or animal body as regards a blood flow in a pulmonary artery (PA), measurement data are recorded, from which at least a part of the blood flow in the pulmonary artery (PA) is able to be re-constructed at least two-dimensionally in a plane defined by a longitudinal axis of the pulmonary artery (PA) and by an anterior-posterior direction, including at least at several diastolic points in time in the course of a heart cycle, after a closure of the pulmonary valve. The measurement data are analyzed as to how many of the at least several diastolic points in time in the flow behavior of the blood flow of the pulmonary artery an asymmetry in relation to the longitudinal axis of the pulmonary artery in the anterior-posterior direction exists. A measure is then determined that characterizes how long, after the closure of the pulmonary valve in the flow behavior of the blood flow of the pulmonary artery, the aforementioned asymmetry exists.

Abstract: Apparatus for decreasing the circulation of money of small denominations and coins, includes a first input unit for inputting the amount to be paid, connected to a central unit, a second input unit for inputting a rounded amount to be paid connected to the central unit and controlling a rounding unit, a display unit showing a rounded payable sum defined by the rounding unit and a printing unit connected to the central unit. A method and arrangement for drawing lots include an input unit for entering data of participation in the drawing, and a drawing centre including a database of game rules, a game rule interpreting unit, an odds creating unit and a drawing unit connected to a prize indicating unit. The input unit is connected to the drawing centre via a control unit; a game database is connected to the control unit.

Abstract: This invention relates to new oxaindene derivatives, a process for the preparation thereof and pharmaceutical compositions comprising the same.The compounds according to the invention are characterized by the general formula (1) ##STR1## wherein R.sup.1 represents lower C.sub.1-4 alkyl, lower C.sub.1-4 alkoxy or lower C.sub.3-6 cycloalkyl,R.sup.2 stands for hydrogen, lower C.sub.1-4 alkyl or lower C.sub.3-6 cycloalkyl,R.sup.3 stands for hydrogen, lower C.sub.1-4 alkyl, lower C.sub.1-4 alkoxy or benzyloxy,X denotes hydrogen, an aliphatic C.sub.1-4 -acyl or benzoyl or naphthoyl group, optionally substituted by 1 or more nitro or C.sub.1-4 -alkoxy group(s) or a group of the formula R.sup.5 R.sup.6 N--R.sup.7 --, wherein R.sup.7 represents lower C.sub.1-4 alkylene and R.sup.5 and R.sup.6 each represent lower C.sub.1-4 alkyl, or R.sup.5 and R.sup.

Abstract: The invention relates to a new process for the preparation of compounds of the Formula I ##STR1## (wherein R stands for hydrogen or methyl) and pharmaceutically acceptable salts thereof which comprises reacting a compound of the Formula V ##STR2## (wherein R.sup.1 and R.sup.2 stand for an aliphatic acyloxy group comprising 2-6 carbon atoms and optionally substituted by halogen: or for an aromatic acyloxy group comprising 7-11 carbon atoms) with an amine of the Formula VI ##STR3## (wherein R has the same meaning as stated above) or a salt thereof and subjecting the compound of the Formula VII ##STR4## thus obtained (wherein R, R.sup.1 and R.sup.2 are as stated above) to hydrolysis after or without isolation and if desired converting the compound of the Formula I thus obtained into a salt thereof or setting free the same from its salt.The compounds of the Formula I are known antibacterial agents.

Abstract: A method of using a compound of the Formula (V) ##STR1## or a pharmaceutically acceptable salt thereof is disclosed, wherein R.sup.1 and R.sup.2 are each C.sub.1 to C.sub.6 aliphatic acyloxy, unsubstituted or substituted by halogen, or are each C.sub.7 to C.sub.

Abstract: The invention relates to an improved process for the preparation of 2,2-dimethyl-5-(2,5-dimethylphenoxy)-pentanoic acid of Formula (I) ##STR1## which comprises reacting an ester of the general Formula (X) ##STR2## wherein X represents halogen and Z stands for a straight or branched chain C.sub.1-8 alkylene group optionally substituted by one or two 2,2-dimethyl-5-halopentanoyloxy group(s), wherein halo represents chlorine or bromine, and in which alkylene group one or two methylene group(s) may be optionally replaced either by hetero atom(s) or by a bivalent heterocyclic group--with an alkali salt of 2,5-dimethylphenol of Formula (II) ##STR3## or with an ester of the latter formed with a lower alkanoic acid, and hydrolizing the aryloxy-substituted ester of the general Formula (XI) thus obtained. ##STR4## Furthermore the invention relates to intermediate compounds of the general Formula (X), wherein X and Z are as stated above, and to a process for the preparation thereof.

Abstract: The invention relates to an improved process for the preparation of 2,2-dimethyl-5-(2,5-dimethylphenoxy)-pentanoic acid of Formula (I) ##STR1## which comprises reacting an ester of the general Formula (X) ##STR2## wherein X represents halogen and Z stands for a straight or branched chain C.sub.1-8 alkylene group optionally substituted by one or two 2,2-dimethyl-5-halopentanoyloxy group(s), wherein halo represents chlorine or bromine, and in which alkylene group one or two methylene group(s) may be optionally replaced either by hetero atom(s) or by a bivalent heterocyclic group--with an alkali salt of 2,5-dimethylphenol of Formula (II) ##STR3## or with an ester of the latter formed with a lower alkanoic acid, and hydrolizing the aryloxy-substituted ester of the general Formula (XI) thus obtained. Furthermore the invention relates to intermediate compounds of the general Formula (X), wherein X and Z are as stated above, and to a process for the preparation thereof.